Top Stories
A Bright Outlook
Natalie Brandweiner talks to Lilly’s William Chin about personalized medicine, partnerships, and using the company’s PD2 initiative is generate new compounds.
Read more
Up Close and Personal
Reinventing big pharma’s corporate image has been pivotal in EMD Serono’s personalized approach. President and CEO Fereydoun Firouz tells NGP’s Natalie Brandweiner about the company’s drive to innovate, its community...
Read more
Golden Age of Discovery
Martin Mackay, Pfizer’s President of Global R&D, explains how in the age of tailored therapies, the end of diseases is in sight, and how the merger with Wyeth will set the company at the forefront of drug discovery.
Read more
Made to Measure
With pipelines running dry and fortunes flagging, the pharmaceutical industry is casting about for a savior. Could individually tailored treatments be the answer? By Marie Shields
Read more
Checkmate
Generic drugs, having long been minor players in the pharmaceutical marketplace, appear to be gaining a strategic advantage. Is this end game for branded products?
Read more